7 May 2025
We are pleased to announce that Astorg, through their Astorg VIII fund, has signed a definitive agreement to acquire a majority stake in Solabia Group (“Solabia” or “the Company”), a global biotechnology ingredient solutions provider, from TA Associates (“TA”), a leading global private equity firm, who will reinvest in the business. Financial terms of the transaction are not disclosed.
Founded in 1972, Solabia specializes in natural active ingredients for the cosmetics, nutraceutical, pharmaceutical, as well as food and clinical testing industries. Leveraging advanced biotechnology capabilities – including fermentation, enzymatic synthesis, plant extraction, and green chemistry – Solabia develops high-performance ingredients that support precise formulation needs and enable differentiated product outcomes for its customers.
The Company holds leading positions across its market segments, driven by technological differentiation. Solabia’s active ingredients play a critical role in its customer formulations and end-products quality, contributing to high customer retention and long-term supplier integration. Solabia is positioned in dynamic and resilient end-markets and benefits from the continued penetration of natural ingredients in substitution to synthetic compounds.
Headquartered in Paris, Solabia operates 11 manufacturing sites and 8 R&D labs worldwide and employs over 900 staff. It is one of the few independent natural active ingredients platforms at scale combining deep technological expertise with strong global distribution capabilities.
Building on Solabia’s strong track record, marked by double-digit growth in the past five years, Astorg, TA and Solabia’s management team will focus on further accelerating international expansion – particularly in the US and Asia – and advancing the Company’s innovation roadmap, while continuing to benefit from strong market tailwinds.
The transaction is subject to customary regulatory approvals and is expected to close in the coming months.
Sycomore Corporate Finance acted as exclusive financial advisor to Solabia’s management team. The transaction team comprised Pierre-Arnaud de Lacharrière, Tristan Dupont, Marion Pouchain, Simon Crouzevialle, and Charles Daisay.